^
BIOMARKER:

ALK-HLA-DRB1 fusion

i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor, HLA-DRB1, Major Histocompatibility Complex, Class II, DR Beta 1, Major Histocompatibility Complex, Class II, DR Beta 1 Precursor, HLA Class II Histocompatibility Antigen, DR-1 Beta Chain, HLA Class II Histocompatibility Antigen, DRB1 Beta Chain, MHC Class II HLA-DR Beta 1 Chain, Human Leucocyte Antigen DRB1, Human Leukocyte Antigen DRB1, Lymphocyte Antigen DRB1, HLA-DR1B, HLA-DRB1, HLA-DRB, DRB1
Entrez ID:
News
Twitter
Trials
ALK-HLA-DRB1 fusion
LUAD
crizotinib
Sensitive: C4 – Case Studies
ALK-HLA-DRB1 fusion
LUAD
ceritinib
Sensitive: C4 – Case Studies